| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
109.12(B) |
| Last
Volume: |
5,365,633 |
Avg
Vol: |
8,385,378 |
| 52
Week Range: |
$48.64 - $77.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
503,645 |
1,002,990 |
2,126,174 |
| Total Sell Value |
$22,679,618 |
$34,760,114 |
$61,125,774 |
$111,248,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
26 |
44 |
80 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcfaul David W |
SVP, International |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,795 |
42,487 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(119,722) |
16,172,921 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(102,016) |
10,356,021 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(113,052) |
16,292,643 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(90,889) |
10,458,037 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(101,721) |
16,405,695 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(89,068) |
10,548,926 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(99,805) |
16,507,416 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(86,080) |
10,637,994 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,946) |
16,607,221 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(79,353) |
10,724,074 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,321) |
16,700,167 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(85,914) |
10,803,427 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(87,364) |
10,889,341 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(102,607) |
16,800,488 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(89,730) |
10,976,705 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(102,850) |
16,903,095 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2010-01-04 |
4 |
D |
$9.01 |
$2,280 |
D/D |
(253) |
19,663 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2010-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
588 |
19,916 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-12-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(96,968) |
17,005,945 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-12-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(83,199) |
11,066,435 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-12-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(99,866) |
17,102,913 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-12-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(85,686) |
11,149,634 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-12-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(87,187) |
11,235,320 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-12-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(101,616) |
17,202,779 |
|
- |
|
1824 Records found
|
|
Page 46 of 73 |
|
|
0.12 (0.16%) 
